title: Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain.
abstract: Human T-cell lymphotropic virus (HTLV) antibody screening is not recommended uniformly before transplantation in Western countries. In the year 2001, the first cases of HTLV-I infection acquired through organ transplantation from one asymptomatic carrier were reported in Europe. All three organ recipients developed a subacute myelopathy shortly after transplantation. This report rose the question about whether to implement universal anti-HTLV screening of all organ donors or selective screening of donors from endemic areas for HTLV-I infection should be carried out. A national survey was conducted thereafter in which anti-HTLV antibodies were tested in 1,298 organ transplant donors and 493 potential recipients. None was seropositive for HTLV-I and only one recipient, a former intravenous (i.v.) drug user, was found to be infected with HTLV-II. In a different survey, HTLV screening was conducted in 1,079 immigrants and 5 (0.5%) were found to be asymptomatic HTLV-I carriers. All came from endemic areas for HTLV-I infection. No cases of HTLV-II infection were found among immigrants. These results support the current policy of mandatory testing of anti-HTLV antibodies in Spain only among organ transplant donors coming from HTLV-I endemic areas or with a highly suspicion of HTLV-I infection.
authors.affiliation: Service of Infectious Diseases, Hospital Carlos III, Madrid, Spain.
authors.forename: Carlos
authors.initials: C
authors.lastname: Toro
authors.forename: Rafael
authors.initials: R
authors.lastname: Benito
authors.forename: Antonio
authors.initials: A
authors.lastname: Aguilera
authors.forename: Sylvina
authors.initials: S
authors.lastname: Bassani
authors.forename: Carmen
authors.initials: C
authors.lastname: Rodríguez
authors.forename: Enrique
authors.initials: E
authors.lastname: Calderón
authors.forename: Estrella
authors.initials: E
authors.lastname: Caballero
authors.forename: Patricia
authors.initials: P
authors.lastname: Alvarez
authors.forename: Juan
authors.initials: J
authors.lastname: García
authors.forename: Manuel
authors.initials: M
authors.lastname: Rodríguez-Iglesias
authors.forename: Ana
authors.initials: A
authors.lastname: Guelar
authors.forename: Jorge
authors.initials: J
authors.lastname: del Romero
authors.forename: Vincent
authors.initials: V
authors.lastname: Soriano
mesh_terms: D015481:HTLV-I Antibodies / Q000097:blood; D015490:HTLV-I Infections / Q000453:epidemiology*; D015368:Human T-lymphotropic virus 1 / Q000145:classification* / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D016036:Seroepidemiologic Studies; D013030:Spain / Q000453:epidemiology; D014019:Tissue Donors; D014180:Transplantation
chemical_list: D015481:HTLV-I Antibodies